1. For Gilead, its coronavirus treatment is icing on the cake— FDA considering virtual advisory panels but delays GSK, Intercept meetings — Sanofi in COVID-19 mRNA vaccine deal with Translate Bio — See more on our front page news Stay updated with the latest pharma-related coronavirus news on our new page
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

Industry Veterans

This board is for reps that have been in the industry for 10 years or more. Newer reps may also post questions, etc., but please be respectful of those with experience.


  1. Industry Veterans - registered posting only

    Sub-forum of the Industry Vets board. Only registered posting will be allowed.
    Discussions:
    2
    Messages:
    17
    RSS

Sort By:
Title
Replies Views
Last Message ↓
  1. Anonymous
    Replies:
    1,572
    Views:
    360,954
  2. RTabler
    Replies:
    0
    Views:
    129
  3. anonymous
    Replies:
    0
    Views:
    261
  4. bnmbarb
    Replies:
    1
    Views:
    305
  5. anonymous5
    Replies:
    0
    Views:
    327
  6. Anonymous
    Replies:
    10
    Views:
    13,866
  7. anonymous
    Replies:
    17
    Views:
    4,116
  8. Anonymous
    Replies:
    6
    Views:
    3,902
  9. Anonymous
    Replies:
    11
    Views:
    2,716
  10. anonymous
    Replies:
    3
    Views:
    2,424
  11. KMaguire
    Replies:
    0
    Views:
    605
  12. anonymous
    Replies:
    0
    Views:
    1,352
  13. USF17
    Replies:
    1
    Views:
    868
  14. anonymous
    Replies:
    3
    Views:
    1,483
  15. Anonymous
    Replies:
    35
    Views:
    67,820
  16. Anonymous
    Replies:
    3
    Views:
    2,661
  17. anonymous
    Replies:
    7
    Views:
    1,982
  18. anonymous
    Replies:
    2
    Views:
    2,276
  19. anonymous
    Replies:
    1
    Views:
    2,257
  20. anonymous
    Replies:
    0
    Views:
    1,804

Thread Display Options

Loading...